The global Clinical Nutrition Market was valued at USD 32.33 billion in 2024 and is projected to reach USD 49.04 billion by 2032, growing at a CAGR of 5.36%. The U.S. market is forecast to expand from USD 9.72 billion to USD 13.90 billion, driven by advancements in medical nutrition therapy.

Increasing rates of chronic illness, an aging population, and greater utilization of clinical nutrition solutions are fueling market growth. Healthcare providers are prioritizing malnutrition prevention, leading to rising demand for enteral and parenteral nutrition products.

Clinical nutrition includes therapeutic diets, enteral and parenteral nutrition, and dietary supplements for specific medical needs. Market adoption is supported by reimbursement structures, hospital nutrition screening, and initiatives to reduce readmissions.

Key companies in the market include Abbott Nutrition, Pfizer Inc., Bayer AG, Nestlé Health Science, and Baxter International Inc. among others. Enteral feeding formulas, oral nutrition, malnutrition, and hospital pharmacies are significant segments in the market.

North America held a 38% share of the global market in 2024, while the Asia Pacific region is expected to record the fastest growth through 2032. Recent developments include product launches and acquisitions by major players in the market.

Approximately 40% of hospitalized patients in the U.S. receive clinical nutrition support. Home enteral nutrition is growing at a rate of 6-7% annually, with protein-rich and immune-support formulas witnessing double-digit growth.

For more in-depth insights and customization options on the Clinical Nutrition Market, visit the provided link. SNS Insider aims to provide clients with the necessary knowledge to navigate changing market conditions and make informed decisions.

Read more at GlobeNewswire: Clinical Nutrition Market to Exceed USD 49.04 Billion by